Burning Rock Biotech Ltd financial data

Symbol
BNR on Nasdaq
Industry
Services-Medical Laboratories
Location
No. 5 Xingdao Ring Road North,, International Bio Island, Guangzhou, Guangdong, China
Latest financial report
20-F - Q4 2023 - Apr 29, 2024

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 86.6M USD -34%
Accounts Receivable, after Allowance for Credit Loss, Current 17.9M USD +12.1%
Inventory, Net 9.72M USD -48.6%
Assets, Current 125M USD -31.8%
Property, Plant and Equipment, Net 18.6M USD -49.1%
Operating Lease, Right-of-Use Asset 1.73M USD -75.2%
Intangible Assets, Net (Excluding Goodwill) 136K USD -52.8%
Other Assets, Noncurrent 718K USD -76.3%
Assets 146M USD -36.4%
Accounts Payable, Current 2.54M USD -65.6%
Employee-related Liabilities, Current 7.16M USD -30.4%
Liabilities, Current 37.1M USD -37.8%
Operating Lease, Liability, Noncurrent 520K USD -73.5%
Other Liabilities, Noncurrent 638K USD +6.69%
Liabilities 38.3M USD -38.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -22.8M USD +5.31%
Retained Earnings (Accumulated Deficit) -543M USD -17%
Stockholders' Equity Attributable to Parent 108M USD -35.6%
Liabilities and Equity 146M USD -36.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 86.7M USD -33.5%
Deferred Tax Assets, Valuation Allowance 75.4M USD +19.1%
Deferred Tax Assets, Gross 75.8M USD +16.1%
Operating Lease, Liability 1.74M USD -76.4%
Lessee, Operating Lease, Liability, to be Paid 1.82M USD -76.5%
Property, Plant and Equipment, Gross 75.5M USD -1.59%
Operating Lease, Liability, Current 1.22M USD -77.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 536K USD -63.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.28M USD -77.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +20.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 81K USD -78.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 543K USD -60.2%
Deferred Tax Assets, Operating Loss Carryforwards 30.7M USD +16.2%
Unrecognized Tax Benefits 2.73M USD +164%
Additional Paid in Capital 683M USD +2.8%
Deferred Tax Assets, Net of Valuation Allowance 392K USD -80.2%